AI assistant
Q32 Bio Inc. — Director's Dealing 2024
Jan 3, 2024
34891_dirs_2024-01-03_ff41c816-084c-4f10-b0c6-d3d3a773a99b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2024-01-01
Reporting Person: Alloway Paul (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-01 | Common Stock | M | 4420 | — | Acquired | 21126 | Direct |
| 2024-01-01 | Common Stock | M | 5280 | — | Acquired | 26406 | Direct |
| 2024-01-01 | Common Stock | M | 8910 | — | Acquired | 35316 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | Restricted Stock Units | $ | M | 4420 | Disposed | Common Stock (4420) | Direct | |
| 2024-01-01 | Restricted Stock Units | $ | M | 5280 | Disposed | Common Stock (5280) | Direct | |
| 2024-01-01 | Restricted Stock Units | $ | M | 8910 | Disposed | Common Stock (8910) | Direct |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.
F3: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.
F4: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.